Cost-effectiveness threshold of Down Syndrome maternal serum markers for cffDNAtest as a second tier

Marie Blanquet (), Charline Mourgues, Stéphanie Leger, Didier Lemery, Laurent Gerbaud, Anne Debost-Legrand () and Françoise Vendittelli
Additional contact information
Anne Debost-Legrand: IP - Institut Pascal - SIGMA Clermont - SIGMA Clermont - UCA [2017-2020] - Université Clermont Auvergne [2017-2020] - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2018-10-14
References: Add references at CitEc
Citations:

Published in XXII World Congress of Gynecology and Obstetrics, Oct 2018, rio de janeiro, Brazil

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02103730

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().